Objective: To determine whether the ovary influences adrenal androgen secre
tion in women with polycystic ovary syndrome (PCOS).
Design: Six PCOS-affected patients with clomiphene resistance and gonadotro
phin hyperresponsivity, and six controls with regular ovulatory cycles, mat
ched for age and body mass index.
Methods: Bilateral ovarian wedge resection was performed to induce ovulatio
n surgically for these refractory women with PCOS. The adrenal androgen sec
retions were evaluated in PCOS patients before and again 6 months after thi
s surgery, and in the controls, using an ACTH stimulation test (0.25 mg syn
thetic ACTH(1-24)).
Results: Biochemically, basal levels and the maximum net increases (Delta)
of 17-hydroxyprogesterone (17-OHP) and androstenedione, Delta 17-OHP/Delta
progesterone and Delta androstenedione/Delta 17-OHP ratios in response to e
xogenous ACTH were significantly higher in PCOS patients before operation t
han those of controls. This purely ovarian surgery in women with PCOS was f
ound to significantly reduce their basal androstenedione, testosterone and
LH levels, insulin/glucose ratio, and post-corticotrophic Delta 17-OHP, Del
ta androstenedione, Delta 17-OHP/Delta progesterone and Delta androstenedio
ne/Delta 17-OHP, without obvious changes in FSH, oestradiol, sex hormone-bi
nding globulin, Delta dehydroepiandrosterone, Delta dehydroepiandrosterone
sulphate, Delta aldosterone and Delta cortisol values.
Conclusions: Ovarian hyperandrogenicity from polycystic ovary may contribut
e to the enhanced adrenal P450c17 alpha activity and subsequent Delta(4) an
drogen reserve revealed by the pharmacological corticotrophin stimulation i
n our special PCOS cases.